Medizinische Universität Graz - Research portal

Logo MUG Resarch Portal

Selected Publication:

SHR Neuro Cancer Cardio Lipid Metab Microb

Kriegl, L; Hatzl, S; Schilcher, G; Zollner-Schwetz, I; Boyer, J; Geiger, C; Hoenigl, M; Krause, R.
Antifungals in Patients With Extracorporeal Membrane Oxygenation: Clinical Implications.
Open Forum Infect Dis. 2024; 11(6): ofae270 Doi: 10.1093/ofid/ofae270 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Leading authors Med Uni Graz
Krause Robert
Kriegl Lisa
Co-authors Med Uni Graz
Boyer Johannes
Hatzl Stefan
Hönigl Martin
Schilcher Gernot
Zollner-Schwetz Ines
Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:
Extracorporeal membrane oxygenation (ECMO) is a life-saving technique used in critical care medicine for patients with severe respiratory or cardiac failure. This review examines the treatment and prophylaxis of fungal infections in ECMO patients, proposing specific regimens based on available data for different antifungals (azoles, echinocandins, amphotericin B/liposomal amphotericin B) and invasive fungal infections. Currently, isavuconazole and posaconazole have the most supported data, while modified dosages of isavuconazole are recommended in ECMO. Echinocandins are preferred for invasive candidiasis. However, choosing echinocandins is challenging due to limited and varied data on concentration loss in the ECMO circuit. Caution is likewise advised when using liposomal amphotericin B due to uncertain concentrations and potential ECMO dysfunction based on scarce data. We further conclude with the importance of further research on the impact of ECMO on antifungal drug concentrations to optimize dosing regimens in critically ill patients.

Find related publications in this database (Keywords)
antifungal prophylaxis
antifungal treatment
extracorporeal membrane oxygenation (ECMO)
fungal infections
intensive care
© Med Uni GrazImprint